Acetylation in cardiovascular diseases: Molecular mechanisms and clinical implications
- 1 October 2020
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1866 (10) , 165836
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of China (91749128, 81770261)
This publication has 102 references indexed in Scilit:
- Calorie Restriction and SIRT3 Trigger Global Reprogramming of the Mitochondrial Protein AcetylomeMolecular Cell, 2013
- Insulin Resistance, Hyperglycemia, and AtherosclerosisCell Metabolism, 2011
- Sirt3 Mediates Reduction of Oxidative Damage and Prevention of Age-Related Hearing Loss under Caloric RestrictionCell, 2010
- SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylationNature, 2010
- The histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces cardiac arrhythmias in dystrophic miceCardiovascular Research, 2010
- The many roles of histone deacetylases in development and physiology: implications for disease and therapyNature Reviews Genetics, 2009
- Catalysis and substrate selection by histone/protein lysine acetyltransferasesCurrent Opinion in Structural Biology, 2008
- Histone deacetylase inhibition reduces myocardial ischemia‐reperfusion injury in miceThe FASEB Journal, 2008
- Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injuryCardiovascular Research, 2007
- Oxidative stress and stress signaling: menace of diabetic cardiomyopathyActa Pharmacologica Sinica, 2005